The Effect of Home-Based Walking Program on Peripheral Neuropathy, Fatigue and Quality of Life
1 other identifier
interventional
88
1 country
1
Brief Summary
The study aims to evaluate the effect of home-based walking program on peripheral neuropathy, fatigue and quality of life in patients receiving taxane and platinum-based chemotherapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 19, 2023
CompletedFirst Posted
Study publicly available on registry
August 25, 2023
CompletedStudy Start
First participant enrolled
September 15, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 20, 2024
CompletedJune 18, 2025
June 1, 2025
12 months
August 19, 2023
June 15, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
International Physical Activity Questionnaire (IPAQ- Short Form)
It is used to evaluate physical activity. The form includes walking, moderate and vigorous activity, sitting categories. The total score includes the sum of time (minutes) and frequency (days).
Baseline and 8th week
National Cancer Institute (NCI) -CTCAE v5.0 Toxicity Criteria
This scale was developed to evaluate the grading of chemotherapy-related peripheral neurotoxicity. It evaluates sensory and motor neuropathy between grades 1-5.
Baseline and 8th week
Cancer Fatigue Scale
This scale was developed to evaluate the fatigue of cancer patients. It includes 15 questions and three sub-dimensions: Physical, Affective and Cognitive. The Likert type form is evaluated by giving points. Increasing scores received from the scale demonstrate a high level of fatigue.
Baseline and 8th week
European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire Chemotherapy-Induced Peripheral Neuropathy (EORTC QLQ-CIPN 20)
This scale was developed to evaluate the effect of peripheral neuropathy on quality of life of cancer patients. It includes 20 questions and three sub-dimensions: Sensory, Motor and Autonomic. The Likert type form is evaluated by giving points. Increasing scores received from the scale demonstrate a high level of symptoms and problems related to peripheral neuropathy.
Baseline and 8th week
European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30)
This Scale was developed to measure the quality of life of patients with cancer. It includes 30 questions and three sub-dimensions: Global health status, Functional, Symptom. High scores in the functional subscale indicate good/healthy functional status, high scores in the symptom subscale indicate high levels of symptoms and/or problems, and high scores in the global health status/quality of life subscale indicate good quality of life.
Baseline and 8th week
Study Arms (2)
Home Based Walking Program
EXPERIMENTALEffect of home-based walking program on peripheral neuropathy, fatigue and quality of life
Control group
NO INTERVENTIONThe control group will be given the "Ministry of Health Physical Activity Guidelines".Routine care.
Interventions
The intervention group will be applied to "Home Based Walking Program". It was aimed that the patients should do at least 150 minutes of moderate-intensity physical exercise per week for up to 8 weeks. The content of the program includes a walking information booklet (information notes, activity chart and obstacle avoidance form), exercise diary, face-to-face-telephone counseling, sending text messages, prepared in line with international guides. It was planned to give weekly counseling to the patients included in the intervention group for an 8-week period.
Eligibility Criteria
You may not qualify if:
- Being bone and brain metastases
- Being peripheral neuropathy due to reasons other than chemotherapy (such as chronic disease, diabetes mellitus, nutritional disorders)
- Skin sensitivity on the hands and feet
- Having cardiovascular, pulmonary, musculoskeletal, or psychological disorders that limit exercise or mobility
- Being in another supportive program
- Being in the very active category according to the "International Physical Activity Scale (IPAQ- Short Form)"
- Being a severity of more than 4 points according to the "Modified Borg Scale (MBS)"
- Being a score of 2 and above according to the "ECOG Performance Scale"
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Akdeniz University
Konyaalti, Antalya, 07058, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Fatma Arikan, PhD, RN
Akdeniz University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Single Blind (Participant, Outcomes Assessor)
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
August 19, 2023
First Posted
August 25, 2023
Study Start
September 15, 2023
Primary Completion
August 30, 2024
Study Completion
December 20, 2024
Last Updated
June 18, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share